BACLIB for AMR
Detection of antimicrobial resistance (e.g., colistin resistance)
ResearchActive
Key Facts
Indication
Detection of antimicrobial resistance (e.g., colistin resistance)
Phase
Research
Status
Active
Company
About Pataigin
Pataigin is a private, pre-revenue diagnostics company based in Cambridge, USA, founded in 2016 (incorporated in 2019). It is commercializing a novel microbial lipid fingerprinting technology platform to enable one-hour pathogen identification directly from clinical specimens. Its lead product, BACLIB, is currently available for Research Use Only (RUO) via an Early Access program, positioning the company in the high-growth rapid diagnostics market. The company's success hinges on translating its strong academic foundation into a clinically validated, market-leading diagnostic test.
View full company profile